Literature DB >> 24265247

Preoperative therapeutic apheresis for severe medically refractory amiodarone-induced thyrotoxicosis: a case report.

Jennifer Yamamoto1, Hanifa Dostmohamed, Isanne Schacter, Robert E Ariano, Donald S Houston, Brenda Lewis, Colleen Knoll, Pamela Katz, Ryan Zarychanski.   

Abstract

INTRODUCTION: Amiodarone is associated with thyroid dysfunction and life-threatening thyrotoxicosis. In medically refractory cases, or where medical therapy is contraindicated, thyroidectomy may be required. To decrease perioperative thyroid storm and to reduce overall surgical risk, apheresis may be considered preoperatively to restore euthyroidism. CASE DESCRIPTION: We report a 46-year-old female with a history of cardiac arrhythmia and tachycardia-induced cardiomyopathy for which she received amiodarone. Months after discontinuation of amiodarone, the patient presented with wide complex tachycardia and symptoms of thyrotoxicosis. Laboratory testing confirmed severe thyrotoxicosis which was subsequently refractory to medical therapy. Total thyroidectomy was required. Following a total of 10 apheresis treatments, thyroid hormone levels were reduced to near normal levels and the patient's symptoms improved. Thyroidectomy was performed without intraoperative or postoperative complication. DISCUSSION: In the setting of life-threatening, medically refractory amiodarone-induced thyrotoxicosis, therapeutic apheresis can effectively reduce thyroid hormone levels and restore a state of clinical and biochemical euthyroidism.
© 2013 Wiley Periodicals, Inc.

Entities:  

Keywords:  hyperthyroidism; plasma exchange therapy; thyroidectomy

Mesh:

Substances:

Year:  2013        PMID: 24265247     DOI: 10.1002/jca.21309

Source DB:  PubMed          Journal:  J Clin Apher        ISSN: 0733-2459            Impact factor:   2.821


  3 in total

1.  Therapeutic plasmapheresis in thyrotoxic patients.

Authors:  Ilgin Yildirim Simsir; Murat Ozdemir; Soner Duman; Mehmet Erdogan; Ayhan Donmez; Ahmet Gokhan Ozgen
Journal:  Endocrine       Date:  2018-07-02       Impact factor: 3.633

2.  THERAPEUTIC PLASMA EXCHANGE AS A BRIDGE TO TOTAL THYROIDECTOMY IN PATIENTS WITH SEVERE THYROTOXICOSIS.

Authors:  Kelsey Tieken; Ameena Madan Paramasivan; Whitney Goldner; Ana Yuil-Valdes; Abbey L Fingeret
Journal:  AACE Clin Case Rep       Date:  2020-09-26

3.  Management of Amiodarone-Induced Thyrotoxicosis at a Cardiac Transplantation Centre.

Authors:  Michelle Isaacs; Monique Costin; Ron Bova; Helen L Barrett; Drew Heffernan; Katherine Samaras; Jerry R Greenfield
Journal:  Front Endocrinol (Lausanne)       Date:  2018-08-22       Impact factor: 5.555

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.